92 related articles for article (PubMed ID: 21194377)
1. PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
Reinhold D; Bank U; Entz D; Goihl A; Stoye D; Wrenger S; Brocke S; Thielitz A; Stefin S; Nordhoff K; Heimburg A; Täger M; Ansorge S
Biol Chem; 2011 Mar; 392(3):233-7. PubMed ID: 21194377
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases.
Kühlmann UC; Chwieralski CE; van den Brule S; Röcken C; Reinhold D; Welte T; Bühling F
Life Sci; 2009 Jan; 84(1-2):1-11. PubMed ID: 18973761
[TBL] [Abstract][Full Text] [Related]
5. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
[TBL] [Abstract][Full Text] [Related]
6. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
7. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
Ansorge S; Bank U; Heimburg A; Helmuth M; Koch G; Tadje J; Lendeckel U; Wolke C; Neubert K; Faust J; Fuchs P; Reinhold D; Thielitz A; Täger M
Clin Chem Lab Med; 2009; 47(3):253-61. PubMed ID: 19327105
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
[No Abstract] [Full Text] [Related]
9. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
11. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
12. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
Reinhold D; Kähne T; Steinbrecher A; Wrenger S; Neubert K; Ansorge S; Brocke S
Biol Chem; 2002; 383(7-8):1133-8. PubMed ID: 12437097
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
[TBL] [Abstract][Full Text] [Related]
15. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
16. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
[TBL] [Abstract][Full Text] [Related]
17. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
Reinhold D; Bank U; Täger M; Ansorge S; Wrenger S; Thielitz A; Lendeckel U; Faust J; Neubert K; Brocke S
Front Biosci; 2008 Jan; 13():2356-63. PubMed ID: 17981717
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
19. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
20. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
